ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2699

Using ICD-10 Codes to Identify Patients with Systemic Sclerosis in the Electronic Health Record

Lia Jamian1, Leslie Crofford2 and April Barnado2, 1Medicine, Vanderbilt University Medical Center, Nashville, TN, 2Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Electronic Health Record and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Sclerosis and Related Disorders – Clinical Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Pragmatic research in rare diseases is difficult, largely limited by small sample size and single center cohort studies.  The electronic health record (EHR) can serve as a powerful tool to study rare diseases, such as systemic sclerosis (SSc), allowing researchers to collect a large cohort of patients across the healthcare system.  To assemble these patients, algorithms are needed to identify these patients accurately. We have previously developed and validated algorithms to identify SSc subjects in the EHR using ICD-9 billing codes, laboratory data, and keywords.  With the widespread implementation of ICD-10 billing codes, we sought to develop algorithms using ICD-10 codes, as well as other clinical data to identify SSc patients in the EHR. Methods: We analyzed data from a de-identified version of Vanderbilt’s EHR that contains over 2.8 million subjects with longitudinal clinical data.  We identified 1899 potential SSc patients with at least one count of the SSc ICD-9 (710.1) or ICD-10 (M34*) codes.  Of these potential subjects, we randomly selected 200 as a training set for chart review to identify true case status.  A subject was defined as a case if diagnosed with SSc by a Vanderbilt or external rheumatologist, dermatologist, or pulmonologist (specialist).  We selected the following algorithm components based on clinical knowledge and available data: SSc ICD-10 codes, positive anti-nuclear antibody (ANA) (titer ≥ 1:80), and a keyword of Raynaud’s phenomenon (RP) in notes. Positive predictive values (PPVs) and sensitivities were calculated for ICD-10 codes, as well as combinations of the above algorithm components. Subjects with an unclear diagnosis by a specialist (n = 24) or missing clinic notes (n = 20) were excluded from the analysis.   Results:  Table 1 provides the PPVs and sensitivities of the algorithms. PPVs were higher for algorithms using ICD-10 codes compared to those using the ICD-9 code.  Algorithms that used only ICD-10 codes without other clinical data performed well, with PPVs ranging from 94 to 96%.  When adding a positive ANA or RP keyword to ICD-10 codes, PPVs increased to 100%.   The algorithm with the highest combined PPV of 100% and sensitivity of 78% was ≥ 2 counts of the SSc ICD-10 codes and a positive ANA or RP keyword.    Conclusion: Overall, the PPVs for algorithms using ICD-10 codes were higher compared to PPVs for ICD-9 codes.  While adding clinical data to algorithms only using ICD-9 codes was needed to improve those algorithms’ PPVs, this was not needed for algorithms using ICD-10 codes. Therefore, using only ICD-10 codes without the addition of clinical data can serve as an efficient and effective way to identify SSc subjects accurately in the EHR.    

Table 1.

Algorithm

Positive Predictive Value

Sensitivity

ICD-9 codes only

 

 

≥ 1 count of the ICD-9 code (710.1)

50%

N/A

≥ 2 counts

68%

85%

≥ 3 counts

82%

77%

≥ 4 counts

90%

67%

ICD-10 codes onlya

 

 

≥ 1 count of the ICD-10 codes

88%

85%

≥ 2 counts

96%

76%

≥ 3 counts

95%

53%

≥ 4 counts

94%

44%

ICD-10 codes AND ANA positiveb

 

 

≥ 1 count of the ICD-10 codes AND ANA

94%

67%

≥ 2 counts AND ANA

100%

75%

≥ 3 counts AND ANA

100%

55%

≥ 4 counts AND ANA

100%

45%

ICD-10 codes AND Raynaud’s (RP) keyword

 

 

≥ 1 count of the ICD-10 codes AND RP

96%

83%

≥ 2 counts AND RP

100%

77%

≥ 3 counts AND RP

100%

57%

≥ 4 counts AND RP

100%

47%

ICD-10 codes, RP, ANA positive

 

 

≥ 1 count of the ICD-10 codes AND ANA OR RP

95%

83%

≥ 2 counts AND ANA OR RP

100%

78%

≥ 3 counts AND ANA OR RP

100%

57%

≥ 4 counts AND ANA OR RP

100%

43%

≥ 1 count AND ANA AND RP

94%

68%

≥ 2 counts AND ANA AND RP

100%

61%

≥ 3 counts AND ANA AND RP

100%

43%

≥ 4 counts AND ANA AND RP

100%

35%

aICD-10 codes used included M34 grouping.

b Anti-nuclear antibody (ANA) positive was defined as ≥ 1:80.

 


Disclosure: L. Jamian, None; L. Crofford, None; A. Barnado, None.

To cite this abstract in AMA style:

Jamian L, Crofford L, Barnado A. Using ICD-10 Codes to Identify Patients with Systemic Sclerosis in the Electronic Health Record [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/using-icd-10-codes-to-identify-patients-with-systemic-sclerosis-in-the-electronic-health-record/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/using-icd-10-codes-to-identify-patients-with-systemic-sclerosis-in-the-electronic-health-record/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology